Gail R.  Wilensky net worth and biography

Gail Wilensky Biography and Net Worth

Director of Quest Diagnostics
Dr. Wilensky, is a Senior Fellow at Project HOPE, an international non-profit health foundation, which she joined in 1993. From 2008 through 2009, Dr. Wilensky served as President of the Defense Health Board, an advisory board in the Department of Defense. From 1997 to 2001, she was the chair of the Medicare Payment Advisory Commission. From 1995 to 1997, she chaired the Physician Payment Review Commission. In 1992 and 1993, Dr. Wilensky served as a deputy assistant to the President of the United States for policy development relating to health and welfare issues. From 1990 to 1992, she was the administrator of the Health Care Financing Administration where she directed the Medicare and Medicaid programs. Dr. Wilensky is a director of UnitedHealthcare Group and ViewRay, Inc. She served as a director of Manor Care Inc. from 1998 until 2009, Gentiva Health Services, Inc. from 2000 until 2009, Cephalon Inc. from 2002 to 2011 and SRA International, Inc. from 2005 to 2011. Dr. Wilensky also served as a Commissioner of the World Health Organization’s Commission on the Social Determinants of Health and as the Non-Department Co-Chair of the Defense Department’s Task Force on the Future of Military Health Care. She has been a director of Quest Diagnostics since January 1997. Dr. Wilensky has extensive experience, including in strategic planning, as a senior advisor to the U.S. government and private enterprises regarding healthcare issues and the operation of the U.S. healthcare system.

What is Gail R. Wilensky's net worth?

The estimated net worth of Gail R. Wilensky is at least $3.11 million as of November 26th, 2019. Dr. Wilensky owns 22,951 shares of Quest Diagnostics stock worth more than $3,109,172 as of April 26th. This net worth approximation does not reflect any other assets that Dr. Wilensky may own. Learn More about Gail R. Wilensky's net worth.

How do I contact Gail R. Wilensky?

The corporate mailing address for Dr. Wilensky and other Quest Diagnostics executives is 500 PLAZA DRIVE, SECAUCUS NJ, 07094. Quest Diagnostics can also be reached via phone at (973) 520-2700 and via email at [email protected]. Learn More on Gail R. Wilensky's contact information.

Has Gail R. Wilensky been buying or selling shares of Quest Diagnostics?

Gail R. Wilensky has not been actively trading shares of Quest Diagnostics in the last ninety days. Most recently, Gail R. Wilensky sold 12,222 shares of the business's stock in a transaction on Tuesday, July 27th. The shares were sold at an average price of $139.30, for a transaction totalling $1,702,524.60. Learn More on Gail R. Wilensky's trading history.

Who are Quest Diagnostics' active insiders?

Quest Diagnostics' insider roster includes Michael Deppe (CAO), Catherine Doherty (SVP), Mark Guinan (CFO), Michael Prevoznik (SVP), Timothy Ring (Director), Stephen Rusckowski (CEO), Daniel Stanzione (Director), and Gail Wilensky (Director). Learn More on Quest Diagnostics' active insiders.

Are insiders buying or selling shares of Quest Diagnostics?

In the last twelve months, insiders at the medical research company sold shares 5 times. They sold a total of 15,150 shares worth more than $1,913,201.65. The most recent insider tranaction occured on February, 29th when SVP Michael E Prevoznik sold 5,611 shares worth more than $706,312.68. Insiders at Quest Diagnostics own 0.8% of the company. Learn More about insider trades at Quest Diagnostics.

Information on this page was last updated on 2/29/2024.

Gail R. Wilensky Insider Trading History at Quest Diagnostics

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/27/2021Sell12,222$139.30$1,702,524.60View SEC Filing Icon  
11/26/2019Sell8,000$107.17$857,360.0022,951View SEC Filing Icon  
2/22/2019Sell8,000$87.78$702,240.0034,604View SEC Filing Icon  
2/4/2015Sell8,000$72.34$578,720.00View SEC Filing Icon  
See Full Table

Gail R. Wilensky Buying and Selling Activity at Quest Diagnostics

This chart shows Gail R Wilensky's buying and selling at Quest Diagnostics by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Quest Diagnostics Company Overview

Quest Diagnostics logo
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, retailers, pharmaceutical companies and insurers, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Read More

Today's Range

Now: $135.47
Low: $134.13
High: $138.60

50 Day Range

MA: $128.89
Low: $123.80
High: $137.55

2 Week Range

Now: $135.47
Low: $119.59
High: $147.96

Volume

1,016,096 shs

Average Volume

1,063,713 shs

Market Capitalization

$15.04 billion

P/E Ratio

18.23

Dividend Yield

2.21%

Beta

0.91